Results 271 to 280 of about 283,997 (324)
Some of the next articles are maybe not open access.
Intensification of Antiretroviral Therapy
AIDS Research and Human Retroviruses, 2001ALTHOUGH IMPORTANT DEVELOPMENTS in antiretroviral treatment have occurred, the ability to durably suppress HIV replication is still quite limited. Current guidelines recommend the introduction of at least two compounds not included in the discontinued regimen for treatment failures.1–3 This approach is based on the assumption that resistance mutations ...
M, Núñez +2 more
openaire +2 more sources
Archives of Pharmacal Research, 2000
As we enter the new millennium, there have been dramatic improvements in the care of patients with HIV infection. These have prolonged life and decreased morbidity and mortality. There are fourteen currently available antiretrovirals approved in the United States for the treatment of this infection.
R, Samuel, B, Suh
openaire +2 more sources
As we enter the new millennium, there have been dramatic improvements in the care of patients with HIV infection. These have prolonged life and decreased morbidity and mortality. There are fourteen currently available antiretrovirals approved in the United States for the treatment of this infection.
R, Samuel, B, Suh
openaire +2 more sources
Clinics in Podiatric Medicine and Surgery, 1998
The use of a combination of more potent antiretroviral agents has resulted in suppression of HIV replication to undetectable levels in many patients. Three classes of antiretroviral drugs are currently available: nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors.
openaire +2 more sources
The use of a combination of more potent antiretroviral agents has resulted in suppression of HIV replication to undetectable levels in many patients. Three classes of antiretroviral drugs are currently available: nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors.
openaire +2 more sources
Pharmacogenetics of antiretroviral therapy
Expert Opinion on Drug Metabolism & Toxicology, 2014Human genetic testing is rapidly entering into most medical disciplines, mainly as a way to predict hereditary conditions including predisposition to cancers or degenerative diseases. Another area of interest for human genomics is to ascertain the therapeutic effect and prevent potential toxicities and/or drug-drug interactions of medication.Several ...
Pablo, Barreiro +4 more
openaire +2 more sources
Journal of the American Academy of Dermatology, 1989
Research into the biology of human immunodeficiency virus type 1 (HIV-1), the causative agent of the acquired immunodeficiency syndrome, has yielded valuable information about the replicative cycle of the virus. The steps involved are (1) attachment of the virus to a receptor protein on the surface of the target cell, (2) entry of the virus into the ...
openaire +2 more sources
Research into the biology of human immunodeficiency virus type 1 (HIV-1), the causative agent of the acquired immunodeficiency syndrome, has yielded valuable information about the replicative cycle of the virus. The steps involved are (1) attachment of the virus to a receptor protein on the surface of the target cell, (2) entry of the virus into the ...
openaire +2 more sources
Update on antiretroviral therapy
Archives of Disease in Childhood, 2009Combination antiretroviral treatment (cART) has been highly successful in preventing mother to child transmission of human immunodeficiency virus (HIV) and in reducing mortality and morbidity in HIV infected children. cART is now recommended for all HIV infected infants and selected older children.
A, Riordan, T, Bugembe
openaire +2 more sources
Advances in antiretroviral therapy
Current Opinion in HIV and AIDS, 2013To review recent data about advances in ART.In the last 2 years, clinical trials have demonstrated the safety and efficacy of three integrase transfer inhibitors [raltegravir (RAL), elvitegravir (EVG) and dolutegravir (DTG)], one new nonnucleoside reverse transcriptase inhibitor [rilpivirine (RIL)] and a new extended release formulation of nevirapine ...
Jose R, Arribas, Joseph, Eron
openaire +2 more sources
Antiretroviral Therapy With Heart
American Journal of Therapeutics, 2009Antiretroviral therapy (ART) has resulted in a substantial improvement in the morbidity and mortality associated with human immunodeficiency virus (HIV) infection. As this population ages, cardiovascular disease is becoming an increasingly important health burden.
Paul, Randell, Graeme, Moyle
openaire +2 more sources
The pharmacogenetics of antiretroviral therapy
Current Opinion in HIV and AIDS, 2006Although the past 20 years have seen many advances in HIV pharmacotherapy, host variability has only been more recently recognized as an important driver of both treatment response and toxicity. This review will focus on the importance of variability in drug metabolizing enzymes and the potential research and clinical applications of these findings in ...
openaire +2 more sources
Pediatric Antiretroviral Therapy
2019Human immunodeficiency virus (HIV) is one of the most serious pediatric infectious diseases, affecting around 3 million children and adolescents worldwide. Lifelong antiretroviral treatment (ART) provides multiple benefits including sustained virologic suppression, restoration and preservation of immune function, decreased morbidity and mortality, and ...
Sahera, Dirajlal-Fargo +2 more
openaire +2 more sources